Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 533

Similar articles for PubMed (Select 16140710)

1.

Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants.

Glasgow TS, Young PC, Wallin J, Kwok C, Stoddard G, Firth S, Samore M, Byington CL.

Pediatrics. 2005 Sep;116(3):696-702.

PMID:
16140710
2.

Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study.

Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, Patel D, Peters MT, Stoll B, Levine OS.

Pediatrics. 2000 Jan;105(1 Pt 1):21-6.

PMID:
10617699
3.

Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.

Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, Pavia AT.

Pediatrics. 2003 May;111(5 Pt 1):964-8.

PMID:
12728072
4.

Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use.

Schrag SJ, Hadler JL, Arnold KE, Martell-Cleary P, Reingold A, Schuchat A.

Pediatrics. 2006 Aug;118(2):570-6.

PMID:
16882809
5.

Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants.

Jauréguy F, Carton M, Panel P, Foucaud P, Butel MJ, Doucet-Populaire F.

J Clin Microbiol. 2004 Nov;42(11):5184-8.

6.

Early-onset group B streptococcal disease in the era of maternal screening.

Puopolo KM, Madoff LC, Eichenwald EC.

Pediatrics. 2005 May;115(5):1240-6.

PMID:
15867030
7.

Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy.

Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sánchez PJ.

Pediatrics. 2003 Mar;111(3):541-7.

PMID:
12612234
8.

The association of intrapartum antibiotic exposure with the incidence and antibiotic resistance of infantile late-onset serious bacterial infections.

Ashkenazi-Hoffnung L, Melamed N, Ben-Haroush A, Livni G, Amir J, Bilavsky E.

Clin Pediatr (Phila). 2011 Sep;50(9):827-33. doi: 10.1177/0009922811406260.

PMID:
21885435
9.

The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.

Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA, Clark P, Weisman LE, Rhoads GG, Kong F, Clemens JD.

Am J Obstet Gynecol. 2001 May;184(6):1204-10.

PMID:
11349189
10.

Risk factors associated with ampicillin-resistant infection in newborns in the era of group B streptococcal prophylaxis.

Rentz AC, Samore MH, Stoddard GJ, Faix RG, Byington CL.

Arch Pediatr Adolesc Med. 2004 Jun;158(6):556-60.

PMID:
15184219
11.

Intrapartum antibiotics for known maternal Group B streptococcal colonization.

Ohlsson A, Shah VS.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007467. doi: 10.1002/14651858.CD007467.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD007467.

PMID:
19588432
12.

The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants.

Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB.

Pediatrics. 2000 Aug;106(2 Pt 1):244-50.

PMID:
10920146
13.

Intrapartum antibiotics for known maternal Group B streptococcal colonization.

Ohlsson A, Shah VS.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD007467. doi: 10.1002/14651858.CD007467.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD007467.

PMID:
23440815
14.

Early-onset neonatal group B streptococcal sepsis: intrapartum antibiotic prophylaxis in the clinical setting.

Gervasio CT, Mantaring BS, Alankar S, Shankaran S.

J Perinatol. 2001 Jan-Feb;21(1):9-14.

PMID:
11268874
15.

Potential consequences of widespread antepartal use of ampicillin.

Towers CV, Carr MH, Padilla G, Asrat T.

Am J Obstet Gynecol. 1998 Oct;179(4):879-83.

PMID:
9790363
16.

Evaluation of universal antenatal screening for group B streptococcus.

Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ.

N Engl J Med. 2009 Jun 18;360(25):2626-36. doi: 10.1056/NEJMoa0806820.

17.

Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis.

Ascher DP, Becker JA, Yoder BA, Weisse M, Waecker NJ, Heroman WM, Davis C, Fajardo JE, Fischer GW.

J Perinatol. 1993 May-Jun;13(3):212-6.

PMID:
8345385
18.

Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis.

Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG.

Pediatrics. 2008 Apr;121(4):689-96. doi: 10.1542/peds.2007-2171.

PMID:
18381532
19.
20.

Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.

Pinto NM, Soskolne EI, Pearlman MD, Faix RG.

J Perinatol. 2003 Jun;23(4):265-71.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk